Page 124 - 《中国药房》2023年3期
P. 124

2012-2021年潜在不适当用药的研究热点与趋势分析                                                        Δ



          乔高星 ,楚尧娟,刘 冲,王淑娟,刘克锋,杜书章(郑州大学第一附属医院药学部,郑州 450002)
                *
                                                       #
          中图分类号  R969.3      文献标志码  A      文章编号  1001-0408(2023)03-0370-06
          DOI  10.6039/j.issn.1001-0408.2023.03.22


          摘   要  目的  通过文献计量学的方法,定量和定性分析潜在不适当用药(PIM)研究的进展,并预测PIM研究的热点和趋势,为我
          国开展PIM研究提供参考。方法  检索Web of Science核心数据库与PIM相关的研究文献,在文献计量在线分析平台和CiteSpace
          5.8.R3软件上分析文献的发表趋势,并对研究结果进行可视化分析,通过gCLUTO软件总结PIM的研究热点。结果  关于PIM的
          研究,2012-2021年的年发文量整体呈持续增长的趋势;美国的发文量最多(241篇);澳大利亚悉尼大学为发文量最多(59篇)的
          研究机构;来自爱尔兰科克大学的O’Mahony D教授发文量最多(23篇);PIM的研究涉及57个学科领域,其中老年学发文量最多
         (384篇);期刊International Journal of Clinical Pharmacy的发文量最多(61篇);期刊Journal of the American Geriatrics Society的总
          被引频次最高(1 197次)。PIM的研究热点主要集中在PIM的标准研究、PIM的安全性与经济性研究、PIM的风险因素研究、慢病
          患者的PIM研究、抗精神病药物的PIM研究、药师参与PIM管理的研究、肿瘤姑息治疗中的PIM研究7个方面。结论  PIM研究的
          热度一直在上升,国家与机构间合作不紧密,需要增进合作。未来我国药师关于PIM的研究重点可能在PIM标准的深度本土化、
          PIM的干预与精准用药指导、专病专药的PIM管理等方面。
          关键词  潜在不适当用药;用药安全;合理用药;可视化分析;文献计量学;研究热点

          Research hotspots and trends on potentially inappropriate medication from 2012 to 2021
          QIAO Gaoxing,CHU Yaojuan,LIU Chong,WANG Shujuan,LIU Kefeng,DU Shuzhang(Dept. of Pharmacy, the
          First Affiliated Hospital of Zhengzhou University, Zhengzhou 450002, China)

          ABSTRACT    OBJECTIVE To quantitatively and qualitatively analyze the progress of potentially inappropriate medication (PIM)
          research by means of bibliometrics, and to predict the hotspots and trends of PIM, so as to provide reference for PIM research in
          China.  METHODS  The  research  literature  related  to  PIM  were  searched  from  Web  of  Science  core  database,  and  the  publication
          trend of the literature was analyzed on the bibliometric online analysis platform and CiteSpace 5.8.R3 software. The research results
          were  visualized  and  analyzed,  and  the  research  hotspots  of  PIM  were  summarized  through  gCLUTO.  RESULTS  About  PIM
          research, the annual number of the literature issued from 2012 to 2021 showed a continuous growth trend totally; the United States
          had the largest number of literature (241 pieces); the University of Sydney in Australia was the research institution with the largest
          number of literature (59 pieces); O’Mahony D from University College Cork, Ireland, published the most literature (23 pieces);
          the  research  of  PIM  involved  57  disciplines,  among  which  there  was  the  largest  number  of  literature  about  gerontology (384
          pieces);  International  Journal  of  Clinical  Pharmacy  was  the  journal  with  the  largest  number  of  literature (61  pieces);  Journal  of
          the  American  Geriatrics  Society  was  cited  most  frequently (1  197  times).  The  hotspots  of  PIM  research  mainly  focused  on  seven
          aspects:  the  standard  of  PIM,  the  safety  and  economy  research  of  PIM,  the  risk  factors  research  of  PIM,  the  PIM  research  of
          chronic patients,  the PIM  research of  antipsychotics,  the research of  pharmacists’  participation in PIM  management,  and the PIM
          research  about  palliative  care  of  tumor  patients.  CONCLUSIONS  The  heat  of  research  on  PIM  has  been  on  the  rise,  and  there  is
          little  cooperation  between  countries  and  institutions,  and  more  cooperation  is  needed.  In  the  future,  the  focus  of  Chinese
          pharmacists’  research  on  PIM  may  be  on  the  deep  localization  of  PIM  standards,  PIM  intervention  and  precise  medication
          guidance, and PIM management of specific diseases and drugs.
          KEYWORDS     potentially inappropriate medication; medication safety; rational drug use; visual analysis; bibliometrics; research
          hotspots


                                                                  潜在不适当用药(potentially inappropriate medica‐
              Δ 基金项目 河 南 省 医 学 科 技 攻 关 计 划 联 合 共 建 项 目(No.    tion,PIM)又称潜在不恰当用药,是指按治疗目的需要
          LHGJ20220390)                                       使用但在使用后发生医疗事故的风险可能超过预期获
             *第一作者 主管药师,硕士。研究方向:医院药学、药物经济学。                   益的高风险用药行为         [1―2] 。研究显示,国外住院患者PIM
          E-mail:qiaogaoxing111@163.com                                         [3]
              # 通信作者 主任药师。研究方向:循证医学、药物经济学。E-                  发生率为 40%~75% ,国内住院患者 PIM 发生率为
                                                                       [4]
          mail:dushuzhang911@163.com                          36%~48% 。PIM 增加了患者住院率和住院患者的不

          · 370 ·    China Pharmacy  2023 Vol. 34  No. 3                               中国药房  2023年第34卷第3期
   119   120   121   122   123   124   125   126   127   128   129